Operating Metrics 營運指標
Johnson & Johnson (JNJ) Operating Metrics 營運指標
Johnson & Johnson JNJ 最近 8 季公司營運 KPI、指標定義、跨期趨勢與官方來源。
資料截至：2026-06-28
最新營運指標
- Innovative Medicine Sales
- $63,136M · 2026-06-28 來源：Johnson & Johnson、Johnson & Johnson、Johnson & Johnson、Johnson & Johnson
- MedTech Sales
- $34,793M · 2026-06-28 來源：Johnson & Johnson、Johnson & Johnson、Johnson & Johnson、Johnson & Johnson
- Oncology Sales
- $27,769M · 2026-06-28 來源：Johnson & Johnson、Johnson & Johnson、Johnson & Johnson、Johnson & Johnson
- DARZALEX Sales
- $15,746M · 2026-06-28 來源：Johnson & Johnson、Johnson & Johnson、Johnson & Johnson、Johnson & Johnson
- CARVYKTI Sales
- $2,333M · 2026-06-28 來源：Johnson & Johnson、Johnson & Johnson、Johnson & Johnson、Johnson & Johnson
季度趨勢
| 指標 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q4 FY2024 | Q3 FY2024 |
|---|---|---|---|---|---|---|---|---|
| Innovative Medicine Sales | $16,384M | $15,426M | $15,763M | $15,563M | $15,202M | $13,873M | $14,332M | $14,580M |
| MedTech Sales | $8,926M | $8,636M | $8,801M | $8,430M | $8,541M | $8,020M | $8,188M | $7,891M |
| Oncology Sales | $7,406M | $6,973M | $6,861M | $6,529M | $6,312M | $5,678M | $5,497M | $5,380M |
| DARZALEX Sales | $4,207M | $3,964M | $3,903M | $3,672M | $3,539M | $3,237M | $3,084M | $3,016M |
| CARVYKTI Sales | $657M | $597M | $555M | $524M | $439M | $369M | $334M | $286M |
資料來源
- Johnson & Johnson reports Q2 2026 results, raises 2026 outlook · Johnson & Johnson · 2026-07-15
- Johnson & Johnson reports Q1 2026 results, raises 2026 outlook · Johnson & Johnson · 2026-04-14
- Johnson & Johnson reports Q4 and Full-Year 2025 results · Johnson & Johnson · 2026-01-21
- Johnson & Johnson Reports Q3 2025 Results; Raises 2025 Sales Outlook · Johnson & Johnson · 2025-10-14